Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms
Kathryn G. Schuff, Shane T. Hentges, Michele A. Kelly, Nadine Binart, Paul A. Kelly, P. Michael Iuvone, Sylvia L. Asa, Malcolm J. Low
Kathryn G. Schuff, Shane T. Hentges, Michele A. Kelly, Nadine Binart, Paul A. Kelly, P. Michael Iuvone, Sylvia L. Asa, Malcolm J. Low
View: Text | PDF
Article Genetics

Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms

  • Text
  • PDF
Abstract

Research Article

Authors

Kathryn G. Schuff, Shane T. Hentges, Michele A. Kelly, Nadine Binart, Paul A. Kelly, P. Michael Iuvone, Sylvia L. Asa, Malcolm J. Low

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
Histological analysis of anterior pituitaries from 14-month-old female m...
Histological analysis of anterior pituitaries from 14-month-old female mice. Top row shows hematoxylin and eosin–stained pituitary sections of wild-type (a), Drd2–/– (b), Prlr–/– (c), and compound mutant (Drd2–/–, Prlr–/–) (d) mice. The wild-type pituitary has a normal architecture and mixture of cells including large acidophilic somatotrophs (asterisks), basophils with juxtanuclear, complex lysosomal bodies (arrows), and scattered chromophobic lactotrophs with clear, juxtanuclear Golgi regions (arrowheads). The three mutant genotypes (b–d) all exhibit peliosis (extravasated erythrocytes not contained in capillaries; diamonds) and hypertrophic lactotrophs with very large Golgi regions (arrowheads) and scattered, large, hyperchromatic, atypical nuclei. Middle row: Gordon-Sweet silver stain shows the normal acinar pattern and reticulin network (arrows) in the wild-type pituitary (e), but reveals significant disruption of the reticulin network in Drd2–/– mice (f) and expanded acini and partial loss of reticulin in the Prlr–/– (g) and compound mutant (Drd2–/–, Prlr–/–) (h) mice, findings that are pathognomonic for adenomatous transformation of pituitary cells. Bottom row: PRL immunohistochemistry. The wild-type pituitary (i) contains many mammosomatotrophs with pale, diffuse immunostaining (arrow) and a few mature active lactotrophs with PRL immunostaining in the Golgi apparatus (arrowheads). Almost all the cells in the Drd2–/– (j) and Prlr–/– (k) tumors are active lactotrophs with PRL immunoreactivity in the Golgi. The compound mutant (Drd2–/–, Prlr–/–) (l) tumor is similar, but has fewer immunopositive cells than either single mutant. Representative fields of adenomas from each genotype are shown. Scale bar represents 20 μm; original magnification: ×100, oil immersion.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts